Chemoinformaics analysis of TERNATIN D1
Molecular Weight | 1784.58 | nRot | 31 |
Heavy Atom Molecular Weight | 1696.88 | nRig | 82 |
Exact Molecular Weight | 1783.46 | nRing | 12 |
Solubility: LogS | -2.769 | nHRing | 6 |
Solubility: LogP | 0.936 | No. of Aliphatic Rings | 8 |
Acid Count | 2 | No. of Aromatic Rings | 4 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 214 | No. of Aliphatic Hetero Cycles | 6 |
No. of Heavy Atom | 127 | No. of Aromatic Carbocycles | 4 |
nHetero | 43 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 87 | No. of Saturated Hetero Cycles | 5 |
No. of Carbon atom | 84 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 34 |
No. of Oxygen atom | 43 | No. of Arom Bond | 34 |
nHA | 40 | APOL | 232.777 |
nHD | 21 | BPOL | 120.263 |
QED | 0.007 |
Synth | 6.338 |
Natural Product Likeliness | 0.575 |
NR-PPAR-gamma | 0.997 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 1 |
HIA | 1 |
CACO-2 | -7.03 |
MDCK | 0.000264539 |
BBB | 0.112 |
PPB | 1.04898 |
VDSS | 0.246 |
FU | 0.0799255 |
CYP1A2-inh | 0.001 |
CYP1A2-sub | 0 |
CYP2c19-inh | 0.004 |
CYP2c19-sub | 0.028 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.926 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.114 |
CYP3a4-inh | 0.014 |
CYP3a4-sub | 0 |
CL | -0.346 |
T12 | 0.231 |
hERG | 0.004 |
Ames | 0.081 |
ROA | 0.044 |
SkinSen | 0.011 |
Carcinogencity | 0.252 |
EI | 0.001 |
Respiratory | 0 |
NR-Aromatase | 0.321 |
Antiviral | Yes |
Prediction | 0.799406 |